CytomX Therapeutics

CTMX · NASDAQ

$2.51+$0.17 (+7.26%)TodayMarket closed ·
Prev close $2.34

Who owns CTMX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 59.3% of CTMX’s shares.

  • Fidelity Management & Research Company LLC12.2%
  • Kynam Capital Management LP10.0%
  • BlackRock Institutional Trust Company, N.A.7.1%
  • State Street Investment Management (US)5.4%
  • Next 6 largest institutions24.5%
  • All other shareholders40.7%
Top institutional holders of CTMX
HolderShares% of shares
Fidelity Management & Research Company LLC26.65M12.24%
Kynam Capital Management LP21.70M9.97%
BlackRock Institutional Trust Company, N.A.15.50M7.12%
State Street Investment Management (US)11.75M5.40%
Longitude Capital Management Co., LLC11.54M5.30%
Perceptive Advisors LLC10.44M4.80%
Bank of America Private Bank9.07M4.16%
Vanguard Capital Management, LLC8.53M3.92%
Point72 Asset Management, L.P.7.81M3.59%
BofA Global Research (US)6.02M2.76%

Largest mutual fund holders

Top mutual fund holders of CTMX
HolderShares% of shares
State Street SPDR S&P Biotech ETF8.40M3.86%
Vanguard Total Stock Market Index Fund6.23M2.86%
Fidelity Select Health Care Portfolio5.00M2.30%
iShares Russell 2000 ETF4.59M2.11%
Fidelity Small Cap Growth Fund3.97M1.82%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $4.95K (1 trade) of CTMX on the open market, with no buys.

Latest CTMX insider transactions
InsiderTypeSharesValue
Carvajal AlejandraAward450.00K—
Carvajal AlejandraAward100.00K—
Fuchs Charles S.Award118.00K—
Su ZhenAward59.00K—
Young Matthew P.Award59.00K—
Mohindru ManiAward59.00K—
Gilbert Halley EAward59.00K—
Ashworth AlanAward59.00K—
Meyers James RAward59.00K—
Jones Elaine VAward59.00K—

Short interest

Settled Sep 30, 2026

Shares short
40.81M
Days to cover
8.67
% of shares outstanding
18.75%
Average daily volume
4.70M
Change since last report
+5.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.